THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 36 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $79,000 | -31.3% | 201,537 | 0.0% | 0.01% | -38.9% |
| Q1 2017 | $115,000 | +29.2% | 201,537 | 0.0% | 0.02% | +5.9% |
| Q4 2016 | $89,000 | -99.9% | 201,537 | 0.0% | 0.02% | -22.7% |
| Q3 2016 | $136,541,000 | +106572.7% | 201,537 | 0.0% | 0.02% | -4.3% |
| Q2 2016 | $128,000 | +37.6% | 201,537 | 0.0% | 0.02% | +27.8% |
| Q1 2016 | $93,000 | -4.1% | 201,537 | 0.0% | 0.02% | +20.0% |
| Q4 2015 | $97,000 | -88.2% | 201,537 | 0.0% | 0.02% | -88.5% |
| Q3 2015 | $820,000 | +0.7% | 201,537 | 0.0% | 0.13% | +33.7% |
| Q2 2015 | $814,000 | -0.5% | 201,537 | 0.0% | 0.10% | -29.0% |
| Q1 2015 | $818,000 | +27.6% | 201,537 | 0.0% | 0.14% | -25.8% |
| Q4 2014 | $641,000 | +46.0% | 201,537 | +65.8% | 0.19% | +44.2% |
| Q3 2014 | $439,000 | -8.7% | 121,537 | 0.0% | 0.13% | -9.8% |
| Q2 2014 | $481,000 | -48.6% | 121,537 | -38.2% | 0.14% | -49.1% |
| Q1 2014 | $936,000 | -19.9% | 196,537 | -21.4% | 0.28% | -38.5% |
| Q4 2013 | $1,168,000 | – | 250,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 270,500 | $1,288,000 | 1.11% |
| Rhenman & Partners Asset Management AB | 196,537 | $936,000 | 0.28% |
| FORTALEZA ASSET MANAGEMENT INC/ | 78,055 | $372,000 | 0.19% |
| Baker Brothers Advisors | 1,826,358 | $8,693,000 | 0.11% |
| Rotella Capital Management, Inc. | 14,600 | $69,000 | 0.08% |
| FRANKLIN STREET ADVISORS INC /NC | 69,700 | $332,000 | 0.07% |
| FEDERATED HERMES, INC. | 3,036,963 | $14,456,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 160,000 | $760,000 | 0.04% |
| SMITH ASSET MANAGEMENT GROUP LP | 200,118 | $953,000 | 0.04% |
| Princeton Alpha Management LP | 22,329 | $106,000 | 0.03% |